The Parkinson's Disease NeuroGenebank at Scripps Clinic Registry

This study is currently recruiting participants.

Verified by Scripps Translational Science Institute, October 2008

Sponsors and Collaborators:	Scripps Translational Science Institute Scripps Clinic, Torrey Pines Scripps Translational Science Institute and Genomic Medicine The Scripps Research Institute
Information provided by:	Scripps Translational Science Institute
ClinicalTrials.gov Identifier:	NCT00766948

Purpose

By creating a neurogenebank from Parkinson's disease patients' blood donations we will ultimately be able to define genes for Parkinson's disease and other neurological conditions.

Condition	Intervention
Parkinson's Disease	Other: Gene Bank

Genetics Home Reference related topics: familial paroxysmal nonkinesigenic dyskinesia Parkinson disease

MedlinePlus related topics: Parkinson's Disease

U.S. FDA Resources

Study Type:	Observational
Study Design:	Cohort, Prospective
Official Title:	The Parkinson's Disease NeuroGenebank at Scripps Clinic Registry

Further study details as provided by Scripps Translational Science Institute:

Estimated Enrollment:	100
Study Start Date:	August 2008
Estimated Study Completion Date:	June 2009
Estimated Primary Completion Date:	June 2009 (Final data collection date for primary outcome measure)

Groups/Cohorts	Assigned Interventions
No Treatment	Other: Gene Bank

Eligibility

Ages Eligible for Study:	30 Years and older
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No
Sampling Method:	Non-Probability Sample

Study Population

Patients 30 years of age or older with the diagnosis idiopathic Parkinson's disease

Criteria

Inclusion Criteria:

Is age 30 years or older at the time of onset of Parkinson's
Has been diagnosed with idiopathic Parkinson's Disease by a Scripps Neurologist
Is reliable, cooperative and willing to comply with all protocol-specified procedures and/or sub-study if consented or have legal representative/guardian willing to do so
Able to understand and grant informed consent or have a legal representative/ guardian who is able to do so

Exclusion Criteria:

Patient has been previously enrolled in The Parkinson's Disease NeuroGenebank at Scripps Clinic Registry
If a blood draw would be contraindicated for any reason
Has a significant chronic medical condition (i.e. CVA, hepatic encephalopathy) which, in the investigator's option, may interfere with the patient's optimal participation in the study
Treatment with any investigational agents or devices within 30 days preceding enrollment in the study
Has undergone ECT within 90 days preceding enrollment in the study

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00766948

Locations

United States, California
Scripps Clinic, Torrey Pines	Recruiting
La Jolla, California, United States, 92037
Contact: Kathryn Hults, RN 858-554-5754 hults.kathryn@scrippshealth.org
Sub-Investigator: Melissa Houser, MD
Principal Investigator: Cinnamon Bloss, PhD
Scripps Translational Science Institute	Recruiting
La Jolla, California, United States, 92037
Contact: Kathryn Hults, RN 858-554-5754 hults.kathryn@scrippshealth.org
The Scripps Research Institute	Recruiting
La Jolla, California, United States, 92037
Contact: Kathryn Hults, RN 858-554-5754 hults.kathryn@scrippshealth.org

Sponsors and Collaborators

Scripps Translational Science Institute

Scripps Clinic, Torrey Pines

Scripps Translational Science Institute and Genomic Medicine

The Scripps Research Institute

More Information

Responsible Party:	Scripps Translational Science Institute and Genomic Medicine ( Cinnamon S. Bloss, Ph.D. )
Study ID Numbers:	HSC# 08-5022
Study First Received:	October 2, 2008
Last Updated:	October 2, 2008
ClinicalTrials.gov Identifier:	NCT00766948
Health Authority:	United States: Institutional Review Board

Study placed in the following topic categories:

Ganglion Cysts
Movement Disorders
Parkinson Disease
Basal Ganglia Diseases

Central Nervous System Diseases
Parkinsonian Disorders
Neurodegenerative Diseases
Brain Diseases

Additional relevant MeSH terms:

Nervous System Diseases

ClinicalTrials.gov processed this record on January 16, 2009